Top

Cancer Cell International

Published in:

Open Access 01-12-2024 | Research

DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation

Published in: Cancer Cell International | Issue 1/2024

Title: DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation
Publication date: 01-12-2024
Published in: Cancer Cell International / Issue 1/2024
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-024-03567-z

The interplay between microRNAs and Nrf2 signaling in human cancers

Open Access
Acute Myeloid Leukemia
Review

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?

Open Access
Cytokines
Review

The role of lncRNA NEAT1 in human cancer chemoresistance

Open Access
Cytostatic Therapy
Review

CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription

Open Access
Breast Cancer
Research

Assessing the impact of extracellular matrix fiber orientation on breast cancer cellular metabolism

Open Access
Breast Cancer
Research

The therapeutic effect of a novel GAPDH inhibitor in mouse model of breast cancer and efficacy monitoring by molecular imaging

Open Access
Breast Cancer
Research

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Keynote series | Spotlight on menopause

Springer Medicine